---
title: Impact of vaccines on transmission and variants
videoId: HR_irr2zyaQ
---

From: [[foundmyfitness]] <br/> 

## Delta Variant's Impact on Transmission

The Delta variant of SARS-CoV-2 has significantly impacted the dynamics of COVID-19 transmission. Earlier variants, such as Alpha and Beta, saw [[covid19_vaccines_and_efficacy | COVID-19 vaccines]] in the United States demonstrating 90-95% efficacy at preventing symptomatic COVID-19. Vaccinated individuals who did get infected also had fewer viral particles and were less likely to transmit the virus compared to unvaccinated individuals <a class="yt-timestamp" data-t="01:44:23">[01:44:23]</a>, <a class="yt-timestamp" data-t="01:44:47">[01:44:47]</a>.

However, the Delta variant, which became dominant around July 2021, changed this landscape <a class="yt-timestamp" data-t="01:45:02">[01:45:02]</a>.

## Vaccine Efficacy Against Infection and Hospitalization

A large Mayo Clinic study, involving 25,000 vaccinated and 25,000 unvaccinated individuals across several U.S. states, examined vaccine efficacy against infection and hospitalization with the Delta variant <a class="yt-timestamp" data-t="01:45:16">[01:45:16]</a>, <a class="yt-timestamp" data-t="01:45:37">[01:45:37]</a>.

*   **Reduced Efficacy Against Infection:** Efficacy for preventing infection significantly decreased. For the Pfizer vaccine, it dropped from 88-93% down to 41% <a class="yt-timestamp" data-t="01:45:59">[01:45:59]</a>. The Moderna mRNA vaccine also saw reduced efficacy against infection, but less dramatically, remaining about 77% effective <a class="yt-timestamp" data-t="01:46:34">[01:46:34]</a>. Despite the reduction, vaccines still reduce overall transmission because a significant percentage of vaccinated people are still not getting infected <a class="yt-timestamp" data-t="01:46:14">[01:46:14]</a>, <a class="yt-timestamp" data-t="01:46:51">[01:46:51]</a>.
*   **Sustained Efficacy Against Hospitalization:** Crucially, both [[covid19_vaccines_and_efficacy | vaccines]] remained highly effective at preventing hospitalizations, with efficacy ranging from 80% to 97% <a class="yt-timestamp" data-t="01:47:04">[01:47:04]</a>. Preventing hospitalizations is vital for protecting the healthcare system from being overwhelmed <a class="yt-timestamp" data-t="01:47:15">[01:47:15]</a>.

An Israeli study on healthcare workers showed that those with lower antibody titers were significantly more likely to experience breakthrough infections <a class="yt-timestamp" data-t="01:52:02">[01:52:02]</a>. Mathematical modeling by the Miles Davenport group, published in *Nature Medicine*, suggested that a six-fold higher antibody titer level is needed to protect against contracting the SARS-CoV-2 virus compared to preventing hospitalization <a class="yt-timestamp" data-t="01:52:20">[01:52:20]</a>.

## Viral Load and Transmission in Vaccinated vs. Unvaccinated Individuals

Initial studies, such as a large UK study, indicated that peak viral loads were similar between vaccinated individuals with breakthrough infections and unvaccinated infected individuals <a class="yt-timestamp" data-t="01:48:25">[01:48:25]</a>. This led to a misconception that [[covid19_vaccines_and_efficacy | vaccines]] do not prevent transmission <a class="yt-timestamp" data-t="01:48:50">[01:48:50]</a>.

However, further research provides a more nuanced picture:
*   **Faster Viral Clearance:** A pre-print study from Singapore (with the Delta variant) found that while initial viral levels were similar, vaccinated individuals cleared the virus faster than unvaccinated ones, leading to a shorter time to a negative PCR test <a class="yt-timestamp" data-t="01:49:13">[01:49:13]</a>, <a class="yt-timestamp" data-t="01:49:35">[01:49:35]</a>.
*   **Lower Viral Load Over Time:** The UK REACT Study, which involves real-time data aggregation, confirmed that vaccinated breakthrough cases generally had a lower viral load when randomly sampled at any point in time compared to unvaccinated individuals <a class="yt-timestamp" data-t="01:50:10">[01:50:10]</a>. This suggests that [[covid19_vaccines_and_efficacy | vaccines]] reduce both overall and onward transmission <a class="yt-timestamp" data-t="01:50:37">[01:50:37]</a>, <a class="yt-timestamp" data-t="01:50:44">[01:50:44]</a>.
*   **Less Infectious Viral Particles:** A Netherlands pre-print study showed that even with similar initial viral loads, viral particles shed from vaccinated healthcare workers were less likely to grow in a viral culture, indicating a reduced likelihood of successful infection <a class="yt-timestamp" data-t="01:53:18">[01:53:18]</a>. This is partly because PCR tests can detect dead viral particles, while vaccinated individuals' immune systems are more effective at neutralizing the virus <a class="yt-timestamp" data-t="01:54:51">[01:54:51]</a>, <a class="yt-timestamp" data-t="01:55:31">[01:55:31]</a>.

## Origin of Variants and Vaccine Pressure

Viruses evolve under selective pressure primarily to become more transmissible, not necessarily more virulent (deadly) <a class="yt-timestamp" data-t="01:58:04">[01:58:04]</a>, <a class="yt-timestamp" data-t="01:58:41">[01:58:41]</a>. Virulence can happen incidentally as a virus becomes more transmissible <a class="yt-timestamp" data-t="01:58:51">[01:58:51]</a>.

Arguments suggesting that [[covid19_vaccines_and_efficacy | vaccines]] create selective pressure for more virulent strains are not supported by evidence <a class="yt-timestamp" data-t="01:57:03">[01:57:03]</a>, <a class="yt-timestamp" data-t="02:02:50">[02:02:50]</a>. Viral variants arise from errors in replication <a class="yt-timestamp" data-t="02:04:16">[02:04:16]</a>. Most, if not all, major variants like Alpha, Beta, Gamma, and Delta emerged from unvaccinated populations where the virus had ample opportunity to replicate <a class="yt-timestamp" data-t="02:04:33">[02:04:33]</a>. If vaccination caused variants, they would likely emerge from highly vaccinated countries like Israel or the United States, which has not been observed <a class="yt-timestamp" data-t="02:05:01">[02:05:01]</a>.

People usually die from COVID-19 days after the primary transmission phase, meaning vaccinated individuals, by preventing death and clearing the virus faster, actually reduce the window for viral replication and mutation <a class="yt-timestamp" data-t="02:01:32">[02:01:32]</a>, <a class="yt-timestamp" data-t="02:02:00">[02:02:00]</a>. Unvaccinated individuals, on the other hand, provide more chances for the virus to replicate and potentially mutate into new variants <a class="yt-timestamp" data-t="02:01:43">[02:01:43]</a>, <a class="yt-timestamp" data-t="02:02:14">[02:02:14]</a>.

The concept of vaccine escape, where variants evade vaccine-produced antibodies, is different from causing more virulent strains. While vaccine escape can make vaccinated individuals more susceptible to infection, it doesn't inherently make the virus more deadly <a class="yt-timestamp" data-t="02:03:01">[02:03:01]</a>, <a class="yt-timestamp" data-t="02:03:10">[02:03:10]</a>.

## T-Cell Response and Protection from Severe Disease

Beyond antibodies, the immune system's T-cell response offers significant protection, particularly against hospitalization and severe disease <a class="yt-timestamp" data-t="02:04:02">[02:04:02]</a>, <a class="yt-timestamp" data-t="02:05:20">[02:05:20]</a>. While the Delta variant has reduced the [[covid19_vaccines_and_efficacy | vaccines']]] ability to prevent transmission, there hasn't been a similar erosion in the prevention of hospitalization and severe disease <a class="yt-timestamp" data-t="02:06:03">[02:06:03]</a>. This sustained protection against severe outcomes is largely attributed to the T-cell response, which targets infected cells within the body, a function antibodies have limited ability to perform <a class="yt-timestamp" data-t="02:06:27">[02:06:27]</a>.

Some evidence suggests that T-cells may even adapt and mutate alongside the virus, further reinforcing their protective role <a class="yt-timestamp" data-t="02:05:33">[02:05:33]</a>, <a class="yt-timestamp" data-t="02:05:46">[02:05:46]</a>. Real-world data consistently supports the effectiveness of [[covid19_vaccines_and_efficacy | vaccines]] in preventing severe COVID-19 <a class="yt-timestamp" data-t="02:06:54">[02:06:54]</a>.

## Debunking the "Vaccines make virus more deadly" Claim

The idea that [[covid19_vaccines_and_efficacy | vaccines]] cause the virus to become more deadly to the unvaccinated is a concern for many, especially for parents of unvaccinated children <a class="yt-timestamp" data-t="01:56:58">[01:56:58]</a>, <a class="yt-timestamp" data-t="01:57:12">[01:57:12]</a>. However, evolutionary biology dictates that viruses are under selective pressure to become more transmissible, not more virulent <a class="yt-timestamp" data-t="01:58:04">[01:58:04]</a>. A virus's survival is not aided by killing its host rapidly, as this limits its ability to reproduce and infect more individuals <a class="yt-timestamp" data-t="01:58:10">[01:58:10]</a>. While increased virulence can occur incidentally with increased transmissibility, it's not the primary evolutionary driver <a class="yt-timestamp" data-t="01:58:54">[01:58:54]</a>.

In fact, vaccines limit transmission, and by doing so, also limit the virus's potential to become more virulent <a class="yt-timestamp" data-t="01:59:16">[01:59:16]</a>. Host mortality from COVID-19 typically occurs days after the transmission phase has ended, meaning vaccinated individuals, by surviving and clearing the virus faster, reduce opportunities for further viral replication and mutation <a class="yt-timestamp" data-t="02:01:32">[02:01:32]</a>.

The analogy between antibiotic resistance in bacteria and vaccine impact on viruses is a false equivalence <a class="yt-timestamp" data-t="02:07:06">[02:07:06]</a>. Antibiotics select for pre-existing resistant bacteria, whereas vaccines prevent viral replication, which is necessary for new resistant viral strains to be created <a class="yt-timestamp" data-t="02:07:28">[02:07:28]</a>. The more people that are vaccinated, the less the virus can replicate, and thus the fewer opportunities it has to mutate into new variants <a class="yt-timestamp" data-t="02:04:16">[02:04:16]</a>.

The UK's experience with its second (non-Delta) and third (Delta) waves illustrates the impact of [[covid19_vaccines_and_efficacy | vaccines]]. While infections soared in both waves, the third wave, with widespread vaccination, did not see a concomitant rise in deaths, unlike the second wave <a class="yt-timestamp" data-t="02:19:53">[02:19:53]</a>. This highlights that while [[covid19_vaccines_and_efficacy | vaccines']] effectiveness against infection might wane, their ability to prevent hospitalizations and deaths remains robust <a class="yt-timestamp" data-t="02:21:08">[02:21:08]</a>.